Company · CIK 0000882796
BIOCRYST PHARMACEUTICALS INC
BCRXSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$7.90−$0.17 (−2.17%)
BCRX · Last trade
- Prev close
- $8.07
- Range (29d)
- $7.79 – $8.78
On the record
Recent filings
- SCHEDULE 13G/ABCRXBIOCRYST PHARMACEUTICALS INC0001231919-26-000919 · 14.7 KBSEC(opens sec.gov)
- SCHEDULE 13GBCRXBIOCRYST PHARMACEUTICALS INC0000093751-26-000420 · 8.1 KBSEC(opens sec.gov)
- 10-QBCRXQuarterly update0001628280-26-053300 · 9.6 MBSEC(opens sec.gov)
- 8-KBCRXCurrent report0001171843-26-005223 · 387.5 KBSEC(opens sec.gov)
- 8-K/ABCRXBIOCRYST PHARMACEUTICALS INC0001171843-26-005168 · 192.4 KBSEC(opens sec.gov)
- 8-KBCRXCurrent report0001171843-26-004333 · 240.7 KBSEC(opens sec.gov)
- 8-KBCRXCurrent report0001171843-26-004096 · 373.0 KBSEC(opens sec.gov)
- 144BCRXBIOCRYST PHARMACEUTICALS INC0001628280-26-036012 · 5.2 KBSEC(opens sec.gov)
- 10-QBCRXQuarterly update0001628280-26-031238 · 8.8 MBSEC(opens sec.gov)
- 8-KBCRXCurrent report0001171843-26-003052 · 324.0 KBSEC(opens sec.gov)
Insiders
- 14159, L.P.10% Owner
- 667, L.P.10% Owner
- ABERCROMBIE GEORGE BDirector
- ALEXANDER W JAMESSR. VP, Chief Medical Officer
- ASELAGE STEVEDirector
- Babu Yarlagadda SChief Discovery Officer
- Baker Biotech Capital (GP), LLC10% Owner
- Baker Bros. Advisors (GP) LLC10% Owner
- BAKER BROS. ADVISORS LP10% Owner
- Baker Bros. Capital (GP), LLC10% Owner
Tickers
Addresses
business
4505 EMPEROR BOULEVARD SUITE 200
DURHAM, NC, 27703
mailing
4505 EMPEROR BOULEVARD SUITE 200
DURHAM, NC, 27703
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies